Information:
Fel:
ID
20108
Beskrivning
Positron Emission Tomography (PET) Using Hormone Receptor Ligands in Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00647790
Länk
https://clinicaltrials.gov/show/NCT00647790
Nyckelord
Versioner (1)
- 2017-02-06 2017-02-06 -
Uppladdad den
6 februari 2017
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Breast Cancer NCT00647790
Eligibility Breast Cancer NCT00647790
- StudyEvent: Eligibility
Similar models
Eligibility Breast Cancer NCT00647790
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Gender
Item
male and female patients
boolean
C0079399 (UMLS CUI [1])
Age at diagnosis
Item
aged 18 or older at the time of breast cancer diagnosis
boolean
C1828181 (UMLS CUI [1])
Invasive breast cancer or surgical excision
Item
patients with invasive breast cancer at least 1 cm in size. patients who have had a prior surgical excision are eligible provided there is a residual of at least a 1 cm area suspected on imaging studies.
boolean
C0853879 (UMLS CUI [1])
C0728940 (UMLS CUI [2])
C0728940 (UMLS CUI [2])
Histopathologic confirmed diagnosis of invasive breast cancer
Item
histopathologic review at mskcc confirming diagnosis of invasive breast cancer (ductal, lobular, or inflammatory breast cancer).
boolean
C0677043 (UMLS CUI [1,1])
C0853879 (UMLS CUI [1,2])
C0853879 (UMLS CUI [1,2])
Operative candidates
Item
patients who are operative candidates. patient will have surgery to include either mastectomy or lumpectomy. radiologic assisted excisions such as needle localization are also eligible.
boolean
C1882154 (UMLS CUI [1,1])
C1518601 (UMLS CUI [1,2])
C1518601 (UMLS CUI [1,2])
Bilateral breast cancer
Item
patients with bilateral breast cancer are eligible.
boolean
C0281267 (UMLS CUI [1])
Metastatic cancer
Item
patients with metastatic cancer, provided they need surgical biopsy.
boolean
C0027627 (UMLS CUI [1])
Sentinel node mapping
Item
patients who are undergoing sentinel node mapping (day before or sameday mapping).
boolean
C1519247 (UMLS CUI [1])
Informed consent
Item
patient must sign informed consent.
boolean
C0021430 (UMLS CUI [1])
Previous or concurrent malignancy
Item
previous or concurrent malignancy (except basal and squamous skin cancer and stage 0 cervical cancer)
boolean
C0006826 (UMLS CUI [1])
Gynaecological status
Item
patients who are pregnant or nursing
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
PET
Item
patients unable to tolerate pet or pet/ct
boolean
C0032743 (UMLS CUI [1])
Active infection, autoimmune or inflammatory disease
Item
patients with known active infection, autoimmune or inflammatory disease such as sarcoidosis, and rheumatoid arthritis.
boolean
C0009450 (UMLS CUI [1])
C0004364 (UMLS CUI [2])
C1290884 (UMLS CUI [3])
C0004364 (UMLS CUI [2])
C1290884 (UMLS CUI [3])
Non invasive breast cancer
Item
patients with non invasive breast cancer such as dcis.
boolean
C0205303 (UMLS CUI [1,1])
C0006142 (UMLS CUI [1,2])
C0006142 (UMLS CUI [1,2])
Prior radiation therapy
Item
patients who have received prior radiation therapy to the affected breast.
boolean
C1522449 (UMLS CUI [1,1])
C0332152 (UMLS CUI [1,2])
C0332152 (UMLS CUI [1,2])
Prior chemotherapy
Item
patients who have received prior chemotherapy, including neoadjuvant chemotherapy or hormonal therapy for breast cancer.
boolean
C1514457 (UMLS CUI [1])
Domestic setting
Item
patients living in a residential care or correctional facility.
boolean
C0442519 (UMLS CUI [1])